Literature DB >> 22012013

"Mycobacterium tilburgii" infection in two immunocompromised children: importance of molecular tools in culture-negative mycobacterial disease diagnosis.

Nico G Hartwig1, Adilia Warris, Esther van de Vosse, Adri G M van der Zanden, Tanja Schülin-Casonato, Jakko van Ingen, Rob van Hest.   

Abstract

"Mycobacterium tilburgii" is a nontuberculous mycobacterium that cannot be cultured by current techniques. It is described as causing disseminated disease in adults. We present the first cases of disseminated disease in 2 immunocompromised children. This paper stresses the importance of molecular techniques for correct mycobacterial identification and guidance to immunological diagnosis.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22012013      PMCID： PMC3233006          DOI： 10.1128/JCM.05460-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Report of the ad hoc committee for the re-evaluation of the species definition in bacteriology.

Authors:  Erko Stackebrandt; Wilhelm Frederiksen; George M Garrity; Patrick A D Grimont; Peter Kämpfer; Martin C J Maiden; Xavier Nesme; Ramon Rosselló-Mora; Jean Swings; Hans G Trüper; Luc Vauterin; Alan C Ward; William B Whitman
Journal:  Int J Syst Evol Microbiol       Date:  2002-05       Impact factor: 2.747

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

3.  Re-analysis of 178 previously unidentifiable Mycobacterium isolates in the Netherlands in 1999-2007.

Authors:  J van Ingen; R de Zwaan; M Enaimi; P N Richard Dekhuijzen; M J Boeree; D van Soolingen
Journal:  Clin Microbiol Infect       Date:  2010-09       Impact factor: 8.067

4.  Localized pulmonary infection associated with Mycobacterium tilburgii in an HIV-infected patient.

Authors:  M Kolditz; M Halank; P Spornraft-Ragaller; H Schmidt; G Höffken
Journal:  Infection       Date:  2005-08       Impact factor: 3.553

5.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

Authors:  A Telenti; F Marchesi; M Balz; F Bally; E C Böttger; T Bodmer
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences.

Authors:  A Roth; M Fischer; M E Hamid; S Michalke; W Ludwig; H Mauch
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 7.  Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae.

Authors:  Esther van de Vosse; Marieke A Hoeve; Tom H M Ottenhoff
Journal:  Lancet Infect Dis       Date:  2004-12       Impact factor: 25.071

Review 8.  Mycobacterial diseases in primary immunodeficiencies.

Authors:  J Reichenbach; S Rosenzweig; R Döffinger; S Dupuis; S M Holland; J L Casanova
Journal:  Curr Opin Allergy Clin Immunol       Date:  2001-12

9.  rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria.

Authors:  Toïdi Adékambi; Philippe Colson; Michel Drancourt
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands.

Authors:  Margje H Haverkamp; Sandra M Arend; Jerome A Lindeboom; Nico G Hartwig; Jaap T van Dissel
Journal:  Clin Infect Dis       Date:  2004-07-23       Impact factor: 9.079
View more
  7 in total

1.  IL-12Rβ1 deficiency and disseminated Mycobacterium tilburgii disease.

Authors:  Kinda Schepers; Liliane Schandené; Jacinta Bustamante; Jean-Paul Van Vooren; Maylis de Suremain; Jean-Laurent Casanova; Jean Cyr Yombi; Frédérique Jacobs; Françoise Mascart; Jean-Christophe Goffard
Journal:  J Clin Immunol       Date:  2013-10-10       Impact factor: 8.317

Review 2.  Current and past strategies for bacterial culture in clinical microbiology.

Authors:  Jean-Christophe Lagier; Sophie Edouard; Isabelle Pagnier; Oleg Mediannikov; Michel Drancourt; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

3.  Disseminated infection with Mycobacterium tilburgii in a male immunocompromised patient.

Authors:  Sarah Temmerman; Linos Vandekerckhove; Erica Sermijn; Dirk Vogelaers; Geert Claeys; Mario Vaneechoutte; Piet Cools; Steven Callens
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

4.  Utility of rpoB gene sequencing for identification of nontuberculous mycobacteria in the Netherlands.

Authors:  Rina de Zwaan; Jakko van Ingen; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

5.  Functional Immune Reconstitution by Interleukin-2 Adjunctive Therapy for HIV/Mycobacterial Co-infection.

Authors:  Jan Heyckendorf; Sven Philip Aries; Ulf Greinert; Elvira Richter; Holger Schultz; Christoph Lange
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

6.  Whole-Genome Sequencing of Mycobacterium tilburgii Strain MEPHI.

Authors:  Jamal Saad; Michel Drancourt; Margaret M Hannan; Patrick J Stapleton; Simon Grandjean Lapierre
Journal:  Microbiol Resour Announc       Date:  2019-10-03

7.  Deletion of the entire interferon-γ receptor 1 gene causing complete deficiency in three related patients.

Authors:  Inge C de Vor; Pomme M van der Meulen; Vincent Bekker; Els M Verhard; Martijn H Breuning; Esther Harnisch; Maarten J D van Tol; Jantien W Wieringa; Esther van de Vosse; Robbert G M Bredius
Journal:  J Clin Immunol       Date:  2016-03-01       Impact factor: 8.317
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.